BENGALURU, India, August 4, 2017 /PRNewswire/ --
In continuation to the letter dated July 15, 2016, we would like to inform you that in accordance with the grant made on August 1, 2016 to Dr. Vishal Sikka, CEO and MD of the Company, 25% of the RSUs numbering 30,175 have vested on August 1, 2017. Dr. Vishal Sikka has exercised the above vested RSUs and has disclosed the transaction to the company in accordance with the continual disclosure provisions of Chapter-III under the SEBI (Prohibition of Insider trading) Regulations, 2015.
This is for your records.
This is a disclosure announcement from PR Newswire.